自动化分析仪检测NSTE-ACS患者血清BNP与sST2水平变化分析被引量：1

Determination of serum levels of BNP and sST2 with automatic biochemical analyzer in patients with NSTE-ACS

导出

摘要目的:探讨自动化分析仪检测非ST段抬高急性冠状动脉综合征(NSTE-ACS)患者血清B型钠尿肽(BNP)与血清可溶性ST2(sST2)水平的变化情况。方法:选择2008年4月至2011年4月在我院就诊的非ST段抬高心肌梗死(NSTEMI)患者139例,不稳定型心绞痛(UA)患者94例和正常体检的健康对照组30名作为研究对象,使用雅培AXSYM全自动发光分析仪进行血清BNP和sST2浓度的定量检测,分别采用微粒子捕捉酶促免疫发光分析技术(MEIA)和酶联免疫吸附试验(ELISA)。结果:健康对照组、UA组和NSTEMI组间的血清BNP水平分分别为16.9±9.7,92.7±68.3和296.7±111.5,(P<0.01),sST2水平分分别为0.65±0.27,0.83±0.22和1.35±0.53,(P<0.01)呈梯度增高,且各组间皆具有显著性差异(P<0.05)。相关分析显示,NSTE-ACS患者血清BNP水平与sST2水平呈显著正相关(r=0.722,P<0.001)。结论:血清BNP和sST2水平检测有助于对NSTE-ACS的诊断。 Objective：To study the efficiency of automatic biochemical analyzer in determination of serum B-type natriuretic peptide （BNP） and soluble ST2 （sST2）in patients with acute coronary syndrome. Methods：From Apr.2008 to Apr.2011, 193 patients with non-Q wave myocardial infarction（NSTEMI）, 94 with unstable angina pectoris （UA） and 30 with complete medical check-up in our hospital were recruited in this study. The serum BNP and soluble ST2 were measured by MEIA and ELISA, respectively. Results：There were significant differences of serum BNP and sST2 in each groups of NSTEMI patients, UA patients and normal controls （P0.05）. One-way ANOVA trend analysis indicated that the mean serum BNP and sST2 increased significantly from normal controls to NSTEMI patients （P0.01）. The serum BNP had a significant correlation with sST2 in patients with acute coronary syndrome （r=0.722, P0.001）. Conclusion：The changes of serum BNP and sST2 contribute to diagnose acute coronary syndrome.

作者高建华林凌云邹文蓉文洪林

机构地区首都医科大学附属北京世纪坛医院检验科北京中医医院检验科北京积水潭医院检验科

出处《中国医学装备》 2011年第12期89-91,共3页 China Medical Equipment

关键词自动化 B型钠尿肽 sST2 急性冠脉综合征 Automation B-type natriuretic peptides Soluble ST2 Acute coronary syndrome

分类号 R541.4 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献6

1李胜远,姜青龙.B型-钠尿肽(BNP)-全新的心脏标志物检测项目[J].江西医学检验,2005,23(4):355-356. 被引量：12
2张强,梁凤焱,杨玉香,刘仲华.B-型钠尿肽系列测定判定急性冠脉综合征患者预后的价值[J].中国心血管病研究,2008,6(4):261-263. 被引量：13
3Weber M, Bazzino O, Navarro Estrada JL, et al.N-Terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission[J]. J Am Coll Cardiol, 2008,51 (12) : 1188-1195.
4Tominaga S. A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor[J]. FEBS Lett, 1989,258(2):301-304.
5Sanada S, Hakuno D, Higgins L J, et al. IL-33 and ST2 comprise a critical biomechanicaUy induced and cardioprotective signaling system[J].J Clin Invest,2007,117(6).1538-1549.
6Sweet M J, Leung BP, Kang D, et al. A novel pathway regulating lipopolysaccharide- induced shock by ST2/T1 via inhibition of Toll like receptor 4 expression[J].J Immunol, 2001,166(11):6633-6639.

二级参考文献20

1[1]Hamm CW,Braunwald E.A classification of unstable angina revisited.Circulation,2000,102:1 18-122.
2[2]Newby LK,Ohman EM,Christeuson RH,et al.Benefit of glycoproteinⅡb/Ⅲa inhibition in patients with acute coronary syndromes and tmponin T-positive status:the paragon-B troponin T substudy.Cireulation,2001,103:2891-2896.
3[3]Harem CW,Bertrand M,Bmunwald E.Acute coronary syndrome without ST elevation:implementation of new guidelines.Lancet,2001,358:1533-1538.
4[4]Sabatine MS,Morrow DA,de Lemos JA,et al.Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes:simultaneous assessment of troponin I,C-reactive protein,and B-type natriuretic peptide.Circulation,2002,105:1760-1763.
5[5]Morrow DA,de Lemos JA.Sabatine MS,et al.Evaluation of B-type natriuretic paptide for risk assessment in unstable angina non-ST-elevation myocardial infarction:B-type natriuretic peptide and prognosis in TACTICS-TM1 18.J Am Coll Cardiol,2002,41:1264-1272.
6[6]Jemberg T,Lindahl B,Siegbahn A,et al.N-terminal pro-brain natriuretic paptide in relation to inflammation,myocardial necrosis.and the effect of an invasive strategy in unstable coronary artery disease.J Am Coll Cardiol,2003,42:1909-1916.
7[7]Omland T,de Lemos JA,Morrow DA,et al.Prognostic value of N-terminal pro-atrial and pro-brain natrituretic peptide in patients with acute coronary syndromes.Am J Cardiol,2002,89:463-465.
8[8]De Lemos JA,Morrow DA,Bentley JH,et al.The prognostic value of B-type natrluretic peptide in patients with acute coronary syndremes.N Engl J Med,2001,345:1014-1021.
9[9]Bibbins-Domingo K,Ansari M,Schiller NB,et al.B-type natriuretic peptide and isehemia in patients with stable coronary disease:data from the Heart and Soul Study.Circulation,2003,108:2987-2992.
10[10]Jemberg T,Stridsberg M,Venge P,et al.N-terminal pro-brain natriuretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elevation.J Am Coll Cardiol,2002,40:437-445.